Patterns and factors among oncology fellows recommending medical cannabis to adults with cancer.

IF 4.3 Q1 PHARMACOLOGY & PHARMACY
Kian Tehranchi, Rushad Patell, Poorva Bindal, Laura Dodge, Jason Freed, Mary Buss, Mara A Schonberg, Ilana Braun, Deepa Rangachari
{"title":"Patterns and factors among oncology fellows recommending medical cannabis to adults with cancer.","authors":"Kian Tehranchi, Rushad Patell, Poorva Bindal, Laura Dodge, Jason Freed, Mary Buss, Mara A Schonberg, Ilana Braun, Deepa Rangachari","doi":"10.1186/s42238-025-00293-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Medical cannabis consumption is rising, but limited evidence informs the safety and efficacy of cannabis use in cancer patients. A national survey of oncology trainees found that most fellows felt insufficiently informed to make clinical recommendations about cannabis.</p><p><strong>Aim: </strong>In this secondary analysis, we aimed to measure how frequently trainees recommend in favor of cannabis and determine factors influencing this clinical practice.</p><p><strong>Methods: </strong>In this cross-sectional survey study for fellows enrolled in oncology training programs across the United States, an online survey assessing trainee practices regarding medical cannabis was sent to 155 oncology fellowship program directors from January - March 2021; who were asked to distribute it to their fellows. The primary outcome was the frequency with which oncology fellows recommended cannabis in the prior year.</p><p><strong>Results: </strong>Nationally, 40 programs from 25 states participated, with 189 of 462 trainees across these programs responding (40.9% response rate). 22% (95% CI: 16.3-29.0%) of participants reported recommending medical cannabis to > 5 patients in the past year. 24% (95% CI: 18.4-30.5%) of participants had prior training in medical cannabis. Regarding participant characteristics, only prior training in medical cannabis was significantly associated with recommending cannabis to > 5 patients (RR: 2.4; 95% CI: 1.4-4.2).</p><p><strong>Conclusions: </strong>With increasing cannabis use among patients with cancer and given that a substantial number of oncology fellows recommend its use, it is crucial that fellowship training incorporate evidence-based curricula regarding medical cannabis use to guide informed decision-making between patients and their fellow providers.</p>","PeriodicalId":101310,"journal":{"name":"Journal of cannabis research","volume":"7 1","pages":"45"},"PeriodicalIF":4.3000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12261571/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cannabis research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42238-025-00293-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Medical cannabis consumption is rising, but limited evidence informs the safety and efficacy of cannabis use in cancer patients. A national survey of oncology trainees found that most fellows felt insufficiently informed to make clinical recommendations about cannabis.

Aim: In this secondary analysis, we aimed to measure how frequently trainees recommend in favor of cannabis and determine factors influencing this clinical practice.

Methods: In this cross-sectional survey study for fellows enrolled in oncology training programs across the United States, an online survey assessing trainee practices regarding medical cannabis was sent to 155 oncology fellowship program directors from January - March 2021; who were asked to distribute it to their fellows. The primary outcome was the frequency with which oncology fellows recommended cannabis in the prior year.

Results: Nationally, 40 programs from 25 states participated, with 189 of 462 trainees across these programs responding (40.9% response rate). 22% (95% CI: 16.3-29.0%) of participants reported recommending medical cannabis to > 5 patients in the past year. 24% (95% CI: 18.4-30.5%) of participants had prior training in medical cannabis. Regarding participant characteristics, only prior training in medical cannabis was significantly associated with recommending cannabis to > 5 patients (RR: 2.4; 95% CI: 1.4-4.2).

Conclusions: With increasing cannabis use among patients with cancer and given that a substantial number of oncology fellows recommend its use, it is crucial that fellowship training incorporate evidence-based curricula regarding medical cannabis use to guide informed decision-making between patients and their fellow providers.

肿瘤研究员向成年癌症患者推荐医用大麻的模式和因素。
背景:医用大麻消费量正在上升,但关于癌症患者使用大麻的安全性和有效性的证据有限。一项针对肿瘤学受训人员的全国性调查发现,大多数研究员觉得自己了解的信息不足,无法就大麻提出临床建议。目的:在这个次要分析中,我们旨在测量受训人员推荐大麻的频率,并确定影响这种临床实践的因素。方法:在这项针对美国肿瘤学培训项目注册的研究员的横断面调查研究中,从2021年1月至3月,向155名肿瘤学奖学金项目主任发送了一份评估实习生医疗大麻实践的在线调查;他们被要求把它分发给他们的同伴。主要结果是肿瘤研究员在前一年推荐使用大麻的频率。结果:在全国范围内,来自25个州的40个项目参与其中,这些项目的462名学员中有189人回应了(40.9%的回复率)。22%(95%置信区间:16.3-29.0%)的参与者报告说,在过去一年中向50名患者推荐了医用大麻。24%(95%置信区间:18.4-30.5%)的参与者事先接受过医用大麻培训。关于参与者特征,只有事先接受过医用大麻培训的人才会向bb50名患者推荐大麻(相对危险度:2.4;95% ci: 1.4-4.2)。结论:随着癌症患者使用大麻的人数不断增加,而且有相当数量的肿瘤学研究员建议使用大麻,因此至关重要的是,研究奖学金培训应纳入关于医用大麻使用的循证课程,以指导患者及其同事之间做出知情决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信